First-in-man trial to investigate single, escalating doses of FV 100 in volunteers.

Trial Profile

First-in-man trial to investigate single, escalating doses of FV 100 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Oct 2008

At a glance

  • Drugs Valnivudine (Primary)
  • Indications Herpes zoster
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 25 Oct 2008 Results were presented at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America - A Joint Meeting.
    • 13 Apr 2008 Results presented at the 21st Annual International Society for Antiviral Research in April 2008.
    • 08 Mar 2008 Status changed from in progress to completed according to a Inhibitex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top